Skip to main content
. 2021 Feb 22;5(1):e000897. doi: 10.1136/bmjpo-2020-000897

Table 1.

Patient demographics and outcomes for infants born less than 29 weeks gestation admitted to neonatal units in England and treated with iNO

2010–2011 2012–2013 2014–2015
Neonatal admissions requiring ≥1 day of intensive care (with and without iNO) 6730 6587 6410
Infants treated with iNO 329 (4.9%*) 611 (9.3%*) 1019 (15.9%*)
Birth weight (g) 790 (65 0,950) 795 (67 0,985) 790 (66 0,985)
Gestational age (weeks) 26 (24, 27) 26 (24, 27) 26 (24, 27)
Male sex 180 (55%) 364 (60%) 553 (54%)
Prolonged rupture of membranes >24 hours† 113 (34.4%) 190 (31.1%) 173 (17.0%)
Surfactant therapy in labour ward or neonatal unit 324 (98.5%) 589 (96.4%) 935 (91.8%)
Initiation of iNO therapy (day) 10 (2,33) 13 (2,46) 18 (3,48)
Duration of iNO therapy (days) 3 (2,5) 2 (1,4) 2 (1,4)
Diagnosis (not mutually exclusive)‡
Respiratory distress§ syndrome 255 (77.5%) 505 (82.7%) 920 (90.3%)
Pulmonary hypoplasia 30 (9.1%) 40 (6.6%) 49 (4.8%)
Pulmonary hypertension 100 (30.4%) 164 (26.8%) 260 (25.5%)
Congenital pneumonia 2 (0.6%) 2 (0.3%) 10 (1.0%)
Congenital diaphragmatic hernia 0 0 1 (0.1%)
Death among infants who received iNO 143 (43.5%) 224 (36.7%) 242 (23.8%)

The denominator for all proportions is the number of babies treated with iNO unless indicated otherwise.

*Denominator is all admissions to neonatal unit admissions requiring ≥1 day of intensive care. All values are given as n, % or median (25th,75th centiles), as appropriate.

†Prolonged rupture of membranes >24 hours uses a combination of discharge diagnoses and recorded duration of rupture of membranes.

‡Extracted codes available in online supplemental file.

§This includes the diagnosis respiratory distress syndrome and signs of respiratory distress of newborn (see online supplemental file 1).

iNO, inhaled nitric oxide.